Tenspolde M, Zimmermann K, Weber LC, Hapke M, et al. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes. J Autoimmun 2019 Jun 5. pii: S0896-8411(19)30165.
PMID: 31176558